Sintered body, method for producing the same, and orthodontic bracket
US-2024300859-A1 · Sep 12, 2024 · US
US9630883B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9630883-B2 |
| Application number | US-201013515413-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 16, 2010 |
| Priority date | Dec 16, 2009 |
| Publication date | Apr 25, 2017 |
| Grant date | Apr 25, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A composite material consisting of aluminium oxide as a ceramic matrix and zirconium oxide dispersed therein. A method for the production thereof, components containing the composite and methods of using the same are also provided.
Opening claim text (preview).
The invention claimed is: 1. A composite material comprising at least 65% by volume aluminum oxide as a ceramic matrix; from 10 to 35% by volume zirconium oxide particles dispersed in said ceramic matrix; a dispersoid phase in the form of platelets, and <0.2 mol % of a chemical stabilizer relative to the zirconium oxide content; wherein, based on the total zirconium oxide content, 80 to 99% of said zirconium oxide is present in the tetragonal phase; wherein the zirconium oxide particles have an average grain size of from 0.1 to 0.5 μm; wherein the chemical stabilizer is selected from the group consisting of Y 2 O 3 , CeO 2 , CaO and MgO; and wherein the platelets of the dispersoid phase enable inelastic micro deformation. 2. The composite material according to claim 1 , wherein the zirconium oxide particles have an average grain size of from 0.15 to 0.25 μm. 3. The composite material according to claim 1 , further comprising a soluble constituent selected from the group consisting of Cr, Fe, Ti, a lanthanide and V. 4. The composite material according to claim 3 , wherein the soluble constituent is an element selected from the group consisting of Cr, Fe and Ti. 5. The composite material according to claim 1 , wherein the particle sizes of the dispersoids are 1 to 5 μm. 6. The composite material according to claim 1 , wherein the dispersoids comprise a substance which does not dissolve in aluminum oxide or in zirconium oxide when the composite material is sintered. 7. The composite material according to claim 1 , wherein the dispersoids are selected from the group consisting of strontium aluminate and lanthanum aluminate. 8. The composite material according to claim 1 , wherein the fracture strength is>1300 MPa. 9. A sintered body comprising the composite material according to claim 1 . 10. A component comprising the composite material according to claim 1 , wherein the composite absorbs energy under dynamic load. 11. The component of claim 10 which is a medical device. 12. An artificial prosthesis comprising the composite material of claim 1 . 13. The artificial prosthesis of claim 12 , which is a hip joint implant or a knee joint implant.
Magnesium oxides or oxide-forming salts thereof · CPC title
Yttrium oxide or oxide-forming salts thereof · CPC title
Stabilised zirconias, e.g. YSZ or cerium stabilised zirconia · CPC title
Annealing after sintering · CPC title
Cerium oxides or oxide-forming salts thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.